EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A novel alternative to the use of antimicrobials: Bacteriophages for combating antimicrobial resistance

Shangle Feng, Shiyu Xie, Fangjing He, Linrui Li, Irma Ares, Marta Martínez, Bernardo Lopez-Torres, María-Rosa Martínez-Larrañaga, Arturo Anadón, Xu Wang, María-Aránzazu Martínez

The Veterinary Journal · 2026-12 · 320 · 106906

DOI: 10.1016/j.tvjl.2026.106906 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Veterinary Journal, 2026-12. Verfasst von Shangle Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultu…. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid emergence of antimicrobial resistance poses a serious challenge to both human and veterinary medicine highlighting the urgent need to develop alternative antimicrobial strategies. Phage therapy has regained attention as a promising approach. However, its application in veterinary practice remains relatively limited. Most existing literature reviews focus on natural phage therapy or the development of individual technologies, and there is a lack of comprehensive analysis regarding the clinical translation of next-generation phage technologies-which have advanced rapidly in recent years-into veterinary medicine. This literature review provides a systematic review of the research progress on phages as an alternative to antimicrobial drugs in the veterinary field, with a particular emphasis on application characteristics, treatment strategies, and challenges across different animal species and infection scenarios. It systematically integrates the next-generation technologies that have driven the recent advancement of phage therapy, elucidating their potential applications in veterinary infection prevention and control from three aspects: (i) enhancing antimicrobial efficacy, (ii) expanding the types of antimicrobial formulations, and (iii) optimizing in vivo delivery performance. This provides a new perspective for the systematic integration and clinical translation of next-generation phage technologies in the veterinary field. Building on this foundation, the review article further proposes an artificial intelligence-based precision phage therapy strategy. By integrating pathogen identification, intelligent phage matching, rational phage design, and dynamic optimization of the treatment process, this approach offers new insights into achieving the precise, standardized, and large-scale application of phage therapy in veterinary medicine.

Schlagwörter

Stichwörter der Autor:innen

Antimicrobial mechanismBacteriophageBacteriophage-antibiotic synergyDual mechanisms of actionResistance mechanisms

Autor:innen und Institutionen

  • National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
  • MAO Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid (UCM), and Research Institute Hospital 12 de Octubre (i+12), Madrid 28040, Spain.
  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid (UCM), and Research Institute Hospital 12 de Octubre (i+12), Madrid 28040, Spain. Electronic address: aanadon@…
  • National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China; MAO Laboratory for Risk As…

Förderung

  • Agencia Estatal de Investigación
  • Ministerio de Ciencia e Innovación
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Feng, S., Xie, S., He, F., Li, L., Ares, I., Martínez, M., Lopez-Torres, B., Martínez-Larrañaga, M. R., Anadón, A., Wang, X., & Martínez, M. A. (2026). A novel alternative to the use of antimicrobials: Bacteriophages for combating antimicrobial resistance. The Veterinary Journal, 320, 106906. https://doi.org/10.1016/j.tvjl.2026.106906

Vancouver

Feng S, Xie S, He F, Li L, Ares I, Martínez M, et al. A novel alternative to the use of antimicrobials: Bacteriophages for combating antimicrobial resistance. The Veterinary Journal. 2026;320:106906. doi:10.1016/j.tvjl.2026.106906

BibTeX
@article{Feng2026,
  author = {Feng, Shangle and Xie, Shiyu and He, Fangjing and Li, Linrui and Ares, Irma and Martínez, Marta and Lopez-Torres, Bernardo and Martínez-Larrañaga, María-Rosa and Anadón, Arturo and Wang, Xu and Martínez, María-Aránzazu},
  title = {A novel alternative to the use of antimicrobials: Bacteriophages for combating antimicrobial resistance},
  journal = {The Veterinary Journal},
  year = {2026},
  volume = {320},
  pages = {106906},
  doi = {10.1016/j.tvjl.2026.106906}
}
Kostenlos starten →